UK Core Implementation Guide STU3 Sequence

Please note:

This version is not suitable for implementation. It's purpose is to provide FHIR assets and guidance in support of Clinical and Technical Assurance Sprint 6. Other versions of the UK Core are available: here
Please follow the guidance in the C&TA Sprint 6 pack to provide feedback.
Please follow the guidance on the Contact Us page if you need any assistance.

`substitution`

Important

Within UK healthcare, substitution is not the norm so the international FHIR definition where "_If nothing is specified substitution may be done._" does not align with UK healthcare prescribing best practice.

It could be unwise to assume all UK implementations will prevent substitution if not explicitly stated, especially if the same clinical system has been previously implemented outside the UK.

Within UK Core this element is mandatory and SHALL have a boolean value of false to denote that substitution is not allowed, unless substitution can occur in a specific case.

Allowing substitution

Where substitution to be be allowed, set to true. The inclusion of the coded reason is optional as the ValueSet defined in FHIR is of limited benefit to UK healthcare.